France – Services de recherche et développement expérimental – REALISATION D'UNE PRESTATION DE SERVICE DE SPECIFICATIONS RELATIVES AU DEVELOPPEMENT DU PRODUIT ET D'UNE SOLUTION ACTIVE METALLIQUE STERILE POUR LE TRAITEMENT D'UNE MALADIE RARE

DeadlineSeptember 30, 2026 at 10:00 AM26 days left

AI summary

This tender concerns research and development services for the creation of specifications and development of a sterile metallic-active pharmaceutical solution intended to treat a rare disease.

#pharmaceutical development#rare disease#sterile formulation#metallic active#france#research services#orphan medicine
Fit for

Pharmaceutical research and development companies, contract research organizations (CROs), or specialized laboratories with demonstrated capability in sterile pharmaceutical formulations and rare disease treatments.

Key requirements

Suppliers must demonstrate expertise in pharmaceutical product development, sterile formulation design, and rare disease therapeutics. Experience with metallic active ingredients and regulatory compliance for orphan medicines is essential.

Frequently asked questions

  • What is this tender about?

    This tender concerns research and development services for the creation of specifications and development of a sterile metallic-active pharmaceutical solution intended to treat a rare disease.

  • What are the requirements for suppliers?

    Suppliers must demonstrate expertise in pharmaceutical product development, sterile formulation design, and rare disease therapeutics. Experience with metallic active ingredients and regulatory compliance for orphan medicines is essential.

  • What type of company should bid?

    Pharmaceutical research and development companies, contract research organizations (CROs), or specialized laboratories with demonstrated capability in sterile pharmaceutical formulations and rare disease treatments.

  • Who is the buyer?

    The buyer is SAYENS (Ex SATT GRAND EST).

  • When does this tender close?

    Submissions close on September 30, 2026.

la réalisation d'une prestation de services relative au développement d'un produit pharmaceutique se présentant sous la forme d'une solution stérile d'un actif métallique et destiné au traitement d'une maladie rare.

Buyer
SAYENS (Ex SATT GRAND EST)
Buyer ID: 50170496900051
64 A, rue Sully - CS 77124, 21071, Dijon cedex
Body responsible for review procedures
SAYENS (Ex SATT GRAND EST)
Buyer ID: 50170496900051
64 A, rue Sully - CS 77124, 21071, Dijon cedex

Computing match…

AI document analysis

We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.

Loading…